U-Blot® Research Grade Anti-Human CD274/PD-L1/B7-H1 (SGNPDL1V)Cat. No. WA1516Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD274/PD-L1/B7-H1 (SGNPDL1V)Cat. No. WA1516
U-Blot® Research Grade Anti-Human CD274/PD-L1/B7-H1 (PDL-GEX)Cat. No. WA1515
U-Blot® Research Grade Anti-Human CD274/PD-L1/B7-H1 (NM-01)Cat. No. WA1514
U-Blot® Research Grade Anti-Human CD274/PD-L1/B7-H1 (MX001)Cat. No. WA1513
U-Blot® Research Grade Anti-Human CD274/PD-L1/B7-H1 (MDX-1105)Cat. No. WA1512
U-Blot® Research Grade Anti-Human CD274/PD-L1/B7-H1 (IMM25011)Cat. No. WA1511
U-Blot® Research Grade Anti-Human CD274/PD-L1/B7-H1 (IMC-001)Cat. No. WA1510
U-Blot® Research Grade Anti-Human CD274/PD-L1/B7-H1 (GR1405)Cat. No. WA1509
U-Blot® Research Grade Anti-Human CD274/PD-L1/B7-H1 (FAZ053)Cat. No. WA1508
U-Blot® Research Grade Anti-Human CD274/PD-L1/B7-H1 (CBT-502)Cat. No. WA1507
U-Blot® Research Grade Anti-Human CD274/PD-L1/B7-H1 (APL 502)Cat. No. WA1506
U-Blot® Research Grade Anti-Human CD274/PD-L1/B7-H1 (ABM101)Cat. No. WA1505